(Q53541333)

English

Intracellular amastigote replication may not be required for successful in vitro selection of miltefosine resistance in Leishmania infantum.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/25877390

Intracellular amastigote replication may not be required for successful in vitro selection of miltefosine resistance in Leishmania infantum. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/25877390

Leishmania infantum

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

S Hendrickx

1

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/25877390

A Mondelaers

2

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/25877390

E Eberhardt

3

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/25877390

L Lachaud

4

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/25877390

P Delputte

5

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/25877390

P Cos

6

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/25877390

L Maes

7

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/25877390

publication date

17 April 2015

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/25877390

Parasitology Research

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/25877390

114

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/25877390

7

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/25877390

2561-2565

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/25877390

Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4460-9

21 January 2018

Proteomic analysis of the soluble proteomes of miltefosine-sensitive and -resistant Leishmania infantum chagasi isolates obtained from Brazilian patients with different treatment outcomes

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4460-9

21 January 2018

Leishmania resistance to miltefosine associated with genetic marker

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4460-9

21 January 2018

In vitro sensitivity testing of Leishmania clinical field isolates: preconditioning of promastigotes enhances infectivity for macrophage host cells

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4460-9

21 January 2018

Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4460-9

21 January 2018

Experimental induction of paromomycin resistance in antimony-resistant strains of L. donovani: outcome dependent on in vitro selection protocol

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4460-9

21 January 2018

Experimental selection of paromomycin and miltefosine resistance in intracellular amastigotes of Leishmania donovani and L. infantum

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4460-9

21 January 2018

An update on the diagnosis and treatment of canine leishmaniosis caused by Leishmania infantum (syn. L. chagasi).

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4460-9

21 January 2018

Leishmania donovani resistance to miltefosine involves a defective inward translocation of the drug

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4460-9

21 January 2018

Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4460-9

21 January 2018

Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4460-9

21 January 2018

Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4460-9

21 January 2018

Leishmaniasis in immunosuppressed individuals

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4460-9

21 January 2018

In vitro susceptibilities of Leishmania donovani promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4460-9

21 January 2018

Drug susceptibility of Leishmania infantum (syn. Leishmania chagasi) isolates from Brazilian HIV-positive and HIV-negative patients

1 reference

https://api.crossref.org/works/10.1007%2FS00436-015-4460-9

21 January 2018

Kala-azar elimination programme in India

1 reference

https://pubmed.ncbi.nlm.nih.gov/25877390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00436-015-4460-9

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/25877390

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/25877390

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53541333&oldid=2212200404"